A Public Health Action Plan To Combat Antimicrobial Resistance (Part I: Domestic Issues); Meeting for Public Comment on the Antimicrobial Resistance Interagency Task Force Annual Report, 20915 [05-8090]

Download as PDF Federal Register / Vol. 70, No. 77 / Friday, April 22, 2005 / Notices through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. and will not require start-up, capital, or labor expenditures by respondents. John D. Graubert, Acting General Counsel. [FR Doc. 05–8045 Filed 4–21–05; 8:45 am] BILLING CODE 6750–01–P 1. Description of the Collection of Information and Proposed Use The FTC proposes to survey up to 10,000 consumers in order to gather specific information on the incidence of consumer fraud in the general population. This information will be collected on a voluntary basis, and the identities of the consumers will remain confidential. Subject to OMB approval for the survey, the FTC has contracted with a consumer research firm to identify consumers and conduct the survey. The results will assist the FTC in determining the incidence of consumer fraud in the general population and whether the type and frequency of consumer frauds is changing, and will inform the FTC about how best to combat consumer fraud. The FTC intends to use a larger sample size than the 2003 survey to allow for a more in-depth analysis of the resulting data. The additional data points will allow for statistically significant samples for particular types of fraud and particular demographic characteristics. The questions will be very similar to the 2003 survey so that the results from the 2003 survey can be used as a baseline for a time-series analysis.3 The FTC may choose to conduct another follow-up survey in approximately two years. 2. Estimated Hours Burden The FTC will pretest the survey on approximately 100 respondents to ensure that all questions are easily understood. This pretest will take approximately 15 minutes per person and 25 hours as a whole (100 respondents × 15 minutes each). Answering the consumer survey will require approximately 15 minutes per respondent and 2,500 hours as a whole (10,000 respondents × 15 minutes each). Thus, cumulative total burden hours for the first year of the clearance will approximate 2,525 hours. 3. Estimated Cost Burden The cost per respondent should be negligible. Participation is voluntary 3 The survey instrument for the 2003 Consumer Fraud Survey is attached as Appendix A to the Report. VerDate jul<14>2003 15:27 Apr 21, 2005 Jkt 205001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention A Public Health Action Plan To Combat Antimicrobial Resistance (Part I: Domestic Issues); Meeting for Public Comment on the Antimicrobial Resistance Interagency Task Force Annual Report The Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and National Institutes of Health (NIH) announce an open meeting concerning antimicrobial resistance. Name: ‘‘A Public Health Action Plan to Combat Antimicrobial Resistance (Part I: Domestic Issues)’’: Meeting for Public Comment on the Antimicrobial Resistance Interagency Task Force Annual Report. Time and Date: 1:30 p.m.–5 p.m., June 29, 2005. Place: Hyatt Regency Bethesda, Haverford/Baccarat Suite, One Bethesda Metro Center, 7400 Wisconsin Avenue at Old Georgetown Road, Bethesda, Maryland, 20814; Telephone: 1–301– 657–1234; Fax: 1–301–657–6453. Status: Open to the public, limited by the space available. Purpose: To present the third annual report of progress by Federal agencies in accomplishing activities outlined in ‘‘A Public Health Action Plan to Combat Antimicrobial Resistance (Part I: Domestic Issues),’’ and solicit comments from the public regarding the annual report. The Action Plan serves as a blueprint for activities of Federal agencies to address antimicrobial resistance. The focus of the plan is on domestic issues. Matters to be Discussed: The agenda will consist of welcome, introductory comments, followed by discussion of four focus areas in sequential plenary sessions lasting up to 45 minutes each. The four focus areas are: Surveillance, Prevention and Control, Research, and Product Development. Session leaders will give a 10 to 15 minute overview at the beginning of each session, then open the meeting for general discussion. Comments and suggestions from the public for Federal agencies related to PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 20915 each of the focus areas will be taken under advisement by the Antimicrobial Resistance Interagency Task Force. The agenda does not include development of consensus positions, guidelines, or discussions or endorsements of specific commercial products. The Action Plan, Annual Report, and meeting agenda will be available at https://www.cdc.gov/drugresistance. The public meeting is sponsored by the CDC, FDA, and NIH, in collaboration with seven other Federal agencies and departments involved in developing and writing ‘‘A Public Health Action Plan to Combat Antimicrobial Resistance (Part I: Domestic Issues).’’ Agenda items are subject to change as priorities dictate. Limited time will be available for oral questions, comments, and suggestions from the public. Depending on the number wishing to comment, a time limit of three minutes may be imposed. In the interest of time, visual aids will not be permitted, although written material may be submitted to the Task Force. Written comments and suggestions from the public are encouraged and can be submitted at the meeting or should be received by the contact person (below) by regular mail or e-mail listed below no later than July 31, 2005. Persons who anticipate attending the meeting are requested to send written notification to the contact person (below) by June 17, 2005, including name, organization (if applicable), address, phone, fax, and e-mail address. Ms. Vickie Garrett, Antimicrobial Resistance, Office of the Director, NCID, CDC, mail stop C–12, 1600 Clifton Road, NE., Atlanta, Georgia 30333; telephone 404–639–2603; fax 404–639–4197; or email aractionplan@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. FOR FURTHER INFORMATION CONTACT: Dated: April 18, 2005. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–8090 Filed 4–21–05; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\22APN1.SGM 22APN1

Agencies

[Federal Register Volume 70, Number 77 (Friday, April 22, 2005)]
[Notices]
[Page 20915]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-8090]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


A Public Health Action Plan To Combat Antimicrobial Resistance 
(Part I: Domestic Issues); Meeting for Public Comment on the 
Antimicrobial Resistance Interagency Task Force Annual Report

    The Centers for Disease Control and Prevention (CDC), Food and Drug 
Administration (FDA), and National Institutes of Health (NIH) announce 
an open meeting concerning antimicrobial resistance.
    Name: ``A Public Health Action Plan to Combat Antimicrobial 
Resistance (Part I: Domestic Issues)'': Meeting for Public Comment on 
the Antimicrobial Resistance Interagency Task Force Annual Report.
    Time and Date: 1:30 p.m.-5 p.m., June 29, 2005.
    Place: Hyatt Regency Bethesda, Haverford/Baccarat Suite, One 
Bethesda Metro Center, 7400 Wisconsin Avenue at Old Georgetown Road, 
Bethesda, Maryland, 20814; Telephone: 1-301-657-1234; Fax: 1-301-657-
6453.
    Status: Open to the public, limited by the space available.
    Purpose: To present the third annual report of progress by Federal 
agencies in accomplishing activities outlined in ``A Public Health 
Action Plan to Combat Antimicrobial Resistance (Part I: Domestic 
Issues),'' and solicit comments from the public regarding the annual 
report. The Action Plan serves as a blueprint for activities of Federal 
agencies to address antimicrobial resistance. The focus of the plan is 
on domestic issues.
    Matters to be Discussed: The agenda will consist of welcome, 
introductory comments, followed by discussion of four focus areas in 
sequential plenary sessions lasting up to 45 minutes each. The four 
focus areas are: Surveillance, Prevention and Control, Research, and 
Product Development. Session leaders will give a 10 to 15 minute 
overview at the beginning of each session, then open the meeting for 
general discussion.
    Comments and suggestions from the public for Federal agencies 
related to each of the focus areas will be taken under advisement by 
the Antimicrobial Resistance Interagency Task Force. The agenda does 
not include development of consensus positions, guidelines, or 
discussions or endorsements of specific commercial products.
    The Action Plan, Annual Report, and meeting agenda will be 
available at https://www.cdc.gov/drugresistance. The public meeting is 
sponsored by the CDC, FDA, and NIH, in collaboration with seven other 
Federal agencies and departments involved in developing and writing ``A 
Public Health Action Plan to Combat Antimicrobial Resistance (Part I: 
Domestic Issues).''
    Agenda items are subject to change as priorities dictate.
    Limited time will be available for oral questions, comments, and 
suggestions from the public. Depending on the number wishing to 
comment, a time limit of three minutes may be imposed. In the interest 
of time, visual aids will not be permitted, although written material 
may be submitted to the Task Force. Written comments and suggestions 
from the public are encouraged and can be submitted at the meeting or 
should be received by the contact person (below) by regular mail or e-
mail listed below no later than July 31, 2005.
    Persons who anticipate attending the meeting are requested to send 
written notification to the contact person (below) by June 17, 2005, 
including name, organization (if applicable), address, phone, fax, and 
e-mail address.

FOR FURTHER INFORMATION CONTACT: Ms. Vickie Garrett, Antimicrobial 
Resistance, Office of the Director, NCID, CDC, mail stop C-12, 1600 
Clifton Road, NE., Atlanta, Georgia 30333; telephone 404-639-2603; fax 
404-639-4197; or e-mail aractionplan@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: April 18, 2005.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 05-8090 Filed 4-21-05; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.